Somaxon Pharmaceuticals Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
36
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
Somaxon Pharmaceuticals General Information
Description
Developer of specialty pharmaceuticals. The company's products are used in the treatment of middle ear infections, head lice and cough and cold.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 3570 Carmel Mountain Road
- Suite 100
- San Diego, CA 92130
- United States
+1 (858) 000-0000
Somaxon Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Somaxon Pharmaceuticals Patents
Somaxon Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20090042972-A1 | Methods of using low-dose doxepin for the improvement of sleep | Inactive | 19-May-2006 | 0000000000 | |
| US-20090042971-A1 | Method of using low-dose doxepin for the improvement of sleep | Inactive | 19-May-2006 | 0000000000 |
Somaxon Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Somaxon Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|